shankar d b's Insider Trades & SAST Disclosures
shankar d b's most recent trade in Natco Pharma Ltd. was a Acquisition of 7,210 Equity Shares done at an average price of Rs. 2 . Disclosure was reported to the exchange on Sept. 28, 2020 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for shankar d b in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natco Pharma | Dr. BUDIDETI SHANKAR REDDY | Designated Person | Acquisition | 28 Sep 2020 | 7,210 | 12,710 (0%) | 0.00% | 2 | 14,420 | 28 Sep 2020 28 Sep 2020 |
Insider Trading | Equity Shares | ESOP |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.